|Will the daleks come|
to Dr Who's aid ...?
jiplp weblog's sidebar poll on what people understand when they see the words "Greek yoghurt" -- a phrase which has been bandied about quite a bit in the courts of England and Wales in recent times. 76 readers have voted, but there are still 23 days to go. Finally, the Afro-IP poll on where the World Intellectual Property Organization should locate its proposed regional African office(s), with 126 votes cast and 8 days to go, shows Kenya marginally ahead of South Africa, while Zimbabwe is a surprising third, extending its lead over fourth-placed Nigeria in a field of 16 countries.
IPKat readers can click here to get their 20% registration discount -- so long as you quote the special VIP Katcode FKW82373IPKBP.
Here's a new book you might want to take a look at: it's Pharmaceutical Innovation, Competition And Patent Law: a Trilateral Perspective, edited by Max Planck Director Josef Drexl and Finnish scholar Nari Lee. Published by Edward Elgar, this book offers the following delightful prospects:
"Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals.A review will appear later this summer on the PatLit weblog. Meanwhile, further information about it may be obtained from its web page here.
Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care".